Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1

Edaravone is a mitochondrially targeted drug with a suggested capability to modify the course of diverse neurological diseases. Nevertheless, edaravone has not been tested yet in the context of spinocerebellar ataxia 1 (SCA1), an incurable neurodegenerative disease characterized mainly by cerebellar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sucha, Martina, Benediktova, Simona, Tichanek, Filip, Jedlicka, Jan, Kapl, Stepan, Jelinkova, Dana, Purkartova, Zdenka, Tuma, Jan, Kuncova, Jitka, Cendelin, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341848/
https://www.ncbi.nlm.nih.gov/pubmed/37445867
http://dx.doi.org/10.3390/ijms241310689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341848/
https://www.ncbi.nlm.nih.gov/pubmed/37445867
http://dx.doi.org/10.3390/ijms241310689

Ejemplares similares